Related references
Note: Only part of the references are listed.An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
Sung-Jun Hong et al.
BIOMEDICINES (2020)
15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis in Ha-ras-transformed Human Breast Epithelial Cells by Targeting IκB kinase-NF-κB Signaling
Hye-Kyung Na et al.
JOURNAL OF CANCER PREVENTION (2020)
15-Deoxy-Δ12,14 prostaglandin J2 Induces Epithelial-to-mesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation
Jeehye Choi et al.
JOURNAL OF CANCER PREVENTION (2020)
15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression
Eun Ji Lee et al.
REDOX BIOLOGY (2019)
HMDB 4.0: the human metabolome database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
15-Deoxy-Delta(12,14)-prostaglandin J(2) activates PI3K-Akt signaling in human breast cancer cells through covalent modification of the tumor suppressor PTEN at cysteine 136
Jinyoung Suh et al.
CANCER LETTERS (2018)
Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells
Young-Il Hahn et al.
SCIENTIFIC REPORTS (2018)
Sensitive mass spectrometric assay for determination of 15-deoxy-Delta(12,14)-prostaglandin J(2) and its application in human plasma samples of patients with diabetes
Jakob Morgenstern et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
Takako Kawakita et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Identification and Structural Analysis of New Nrf2 Activators by Mechanism-Based Chemical Transformation of 15-Deoxy-12,14-PGJ2
Kyeojin Kim et al.
CHEMBIOCHEM (2016)
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
Daniel P. Ball et al.
ONCOTARGET (2016)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry
Sibylle Heidelberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Quantitative Assessment of In-solution Digestion Efficiency Identifies Optimal Protocols for Unbiased Protein Analysis
Ileana R. Leon et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Novel Multiplexed Assay for Identifying SH2 Domain Antagonists of STAT Family Proteins
Kazuyuki Takakuma et al.
PLOS ONE (2013)
Molecular Dynamics Studies of the STAT3 Homodimer:DNA Complex: Relationships between STAT3 Mutations and Protein-DNA Recognition
Jarmila Husby et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Bikash Debnath et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Brent D. G. Page et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
STAT3 SIGNALING: Anticancer Strategies and Challenges
Paul A. Johnston et al.
MOLECULAR INTERVENTIONS (2011)
A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro
Wei Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
15d-PGJ(2) Induces Apoptosis by Reactive Oxygen Species-mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity
Sung-Won Shin et al.
CLINICAL CANCER RESEARCH (2009)
Accumulation of 15-deoxy-Δ12,14-prostaglandin J2 adduct formation with Keap1 over time:: effects on potency for intracellular antioxidant defence induction
Joo Yeun Oh et al.
BIOCHEMICAL JOURNAL (2008)
Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening
Wenshan Hao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
15-Deoxy-Δ12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells:: a potential role of ROS
Eun-Hee Kim et al.
CARCINOGENESIS (2008)
Targeting Protein-Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small-Molecule, Nonpeptidic SH2 Domain Binders
Patrick T. Gunning et al.
CHEMBIOCHEM (2008)
STAT3 as a target for cancer drug discovery
Luca Costantino et al.
CURRENT MEDICINAL CHEMISTRY (2008)
SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta 1 by regulating JAK2/STAT3 signaling in pancreas
Ji Hoon Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
PPAR gamma and PPAR delta as Modulators of Neoplasia and Cell Fate
Robert I. Glazer et al.
PPAR RESEARCH (2008)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
15-deoxy-Δ12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-α via covalent modification of DNA-binding domain
Han-Jong Kim et al.
CANCER RESEARCH (2007)
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Xiaodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
15-deoxy-Δ12,14-prostaglandin J2 suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells
BS Wung et al.
LIFE SCIENCES (2006)
Investigation of the binding determinants of phosphopeptides targeted to the Src homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor
DR Coleman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells:: Possible protection by NF-κB and ERK/MAPK
ZH Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Δ12,14-prostaglandin J2
JD Ji et al.
RHEUMATOLOGY (2005)
15-deoxy-Δ12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes
HJ Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
Peroxisome proliferator-activated receptor δ and γ agonists differentially alter tumor differentiation and progression during mammary carcinogenesis
YZ Yin et al.
CANCER RESEARCH (2005)
α,β-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor
T Shiraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ligands of peroxisome proliferator-activated receptor γ inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression
SW Han et al.
CHEST (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress
L Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ2 in oral squamous carcinoma cells
H Siavash et al.
BRITISH JOURNAL OF CANCER (2004)
Protein thiol modification by 15-deoxy-Δ12,14-prostaglandin J2 addition in mesangial cells:: Role in the inhibition of pro-inflammatory genes
FJ Sánchez-Gómez et al.
MOLECULAR PHARMACOLOGY (2004)
Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Δ12,14-prostaglandin J2
D Pérez-Sala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation
J Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Thioredoxin as a molecular target of cyclopentenone prostaglandins
T Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Δ12,14prostaglandin J2 in MCF7 breast cancer cells
CM Paumi et al.
BIOCHEMISTRY (2003)
The cyclopentenone 15-deoxy-Δ12,14-prostagland in J2 binds to and activates H-Ras
JL Oliva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase
PJ Moos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells
NG Nikitakis et al.
BRITISH JOURNAL OF CANCER (2002)
15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells
CE Clay et al.
JOURNAL OF LIPID RESEARCH (2002)
Interdomain interaction of Stat3 regulates its Src homology 2 domain-mediated receptor binding activity
T Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages
YC Fu et al.
ATHEROSCLEROSIS (2002)
15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells
K Takeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Early de novo gene expression is required for 15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis in breast cancer cells
CE Clay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation
J Turkson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
15-deoxy-Δ 12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit
E Cernuda-Morollón et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
R Garcia et al.
ONCOGENE (2001)
A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARγ
WA Wilmer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Nuclear export signal located within the DNA-binding domain of the STAT1 transcription factor
KM McBride et al.
EMBO JOURNAL (2000)
The coiled-coil domain of Stat3 is essential for its SH2 domain-mediated receptor binding and subsequent activation induced by epidermal growth factor and interleukin-6
T Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor
MS Ali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
15-deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
DS Straus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
